Detalhe da pesquisa
1.
Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial.
Hum Vaccin Immunother
; 20(1): 2330770, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38602539